Big news dropped for diabetics this week. The U.S. Food and Drug Administration (FDA) has approved three new medications to help control blood sugar in adults with type 2 diabetes.
The FDA press release specifically stated that these three new treatments – Nesina, Kazana, and Oseni – are to be used with diet and exercise to manage blood sugar. Alogliptin is a new active ingredient found in these treatments.
“These new approvals are what I like to call ‘piggy-back’ drugs. They will reap the rewards of their predecessors like Byetta, Januvia and Victoza,” commented our resident pharmacist, Dr. Sarah G. Khan. She explained that these new drugs give patients more options. For instance, patients could receive discount cards to try the new drugs, it may force insurance companies to prefer the older drugs, or if a patient hasn’t found success with one of those they may with the new drugs.
Read Full Post >